Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Research

• Publication date

  2011-09-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-11-1523PMID 21937684
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis

  2011cited by this paper
• Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway

  2010cited by this paper
• A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

  2010cited by this paper
• Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger

  2009cited by this paper
• LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer.

  2009influential reference
• ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis

  2009cited by this paper
• Mechanisms involved in the regulation of histone lysine demethylases.

  2008cited by this paper
• Regulation of histone methylation by demethylimination and demethylation

  2007cited by this paper
• RBP2‐H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells

  2007influential reference
• JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer

  2007cited by this paper
• How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers

  2007cited by this paper
• PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation.

  2007cited by this paper
• The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases.

  2007cited by this paper
• A chromatin landmark and transcription initiation at most promoters in human cells.

  2007cited by this paper
• Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark.

  2007cited by this paper
• Functional Analysis of the Transcription Repressor PLU-1/JARID1B

  2007cited by this paper
• The human Mi-2/NuRD complex and gene regulation

  2007cited by this paper
• Functional Interplay between Histone Demethylase and Deacetylase Enzymes

  2006cited by this paper
• Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells.

  2006influential reference
• The many roles of chemokines and chemokine receptors in inflammation.

  2006cited by this paper
• Hidden Markov Models, Grammars, and Biology: a Tutorial

  2005cited by this paper
• An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation

  2005cited by this paper
• Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas

  2005cited by this paper
• Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis

  2005cited by this paper
• Regulation of LSD1 histone demethylase activity by its associated factors.

  2005cited by this paper
• Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.

  2004cited by this paper
• Human PLU-1 Has Transcriptional Repression Properties and Interacts with the Developmental Transcription Factors BF-1 and PAX9*

  2003cited by this paper
• Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

  2000cited by this paper
• A Novel Gene (PLU-1) Containing Highly Conserved Putative DNA/Chromatin Binding Motifs Is Specifically Up-regulated in Breast Cancer*

  1999cited by this paper
• NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities.

  1998cited by this paper
• The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.

  1998cited by this paper
• Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase.

  1997cited by this paper
• Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

  1995cited by this paper
• The basement-membrane-like matrix of the mouse EHS tumor: II. Immunohistochemical quantitation of six of its components.

  1985cited by this paper
• Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins

  year unknowncited by this paper

• Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response prediction

  2025cites this paper
• How histone modifications influence cellular radiosensitivity: Pharmaceutically targeting epigenetic regulators as a promising avenue to overcome radioresistance

  2025cites this paper
• BC-predict: mining of signal biomarkers and production of models for early-stage breast cancer subtyping and prognosis

  2025cites this paper
• Identification of potential drug targets and possible drugs for esophageal carcinoma from genetic insights: a comprehensive two-sample Mendelian randomization study

  2025cites this paper
• Epigenetic modifications in breast cancer: from immune escape mechanisms to therapeutic target discovery

  2025cites this paper
• Histone lysine demethylases in breast cancer: molecular mechanisms, biological functions, and therapeutic intervention

  2025cites this paper
• Loss of LSD1 ameliorates myocardial infarction by regulating angiogenesis via transcriptional activation of Vegfa.

  2025cites this paper
• Chemokine ligand 14 correlates with immune cell infiltration in the gastric cancer microenvironment in predicting unfavorable prognosis

  2024cites this paper
• Inhibition of endothelial histone deacetylase 2 shifts endothelial-mesenchymal transitions in cerebral arteriovenous malformation models

  2024cites this paper
• KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges

  2024cites this paper
• Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies.

  2024cites this paper
• The mechanism of USP43 in the development of tumor: a literature review

  2024cites this paper
• HOXD3 promotes the migration and angiogenesis of hepatocellular carcinoma via modifying hepatocellular carcinoma cells exosome-delivered CCR6 and regulating chromatin conformation of CCL20

  2024cites this paper
• Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications

  2024cites this paper
• The emerging roles of histone demethylases in cancers

  2024cites this paper
• Recent advances targeting chemokines for breast cancer.

  2024cites this paper
• ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancer

  2024cites this paper
• Unlocking the dual role of LSD1 in tumor immunity: innate and adaptive pathways

  2024cites this paper
• Deciphering the potential role of post-translational modifications of histones in gastrointestinal cancers: a proteomics-based review with therapeutic challenges and opportunities

  2024cites this paper
• Targeting LSD1 in cancer: molecular elucidation and recent advances.

  2024cites this paper
• KDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells

  2024cites this paper
• A truncated and catalytically inactive isoform of KDM5B histone demethylase accumulates in breast cancer cells and regulates H3K4 tri-methylation and gene expression

  2023influential citation
• KDM5B predicts temozolomide-resistant subclones in glioblastoma

  2023cites this paper
• Exploring the potential of histone demethylase inhibition in multi-therapeutic approaches for cancer treatment.

  2023cites this paper
• LSD1 in drug discovery: From biological function to clinical application

  2023cites this paper
• A two-sample Mendelian randomization analysis: causal association between chemokines and pan-carcinoma

  2023cites this paper
• The proteasome component PSMD14 drives myelomagenesis through a histone deubiquitinase activity.

  2023cites this paper
• Epigenetic regulation of breast cancer metastasis

  2023cites this paper
• Proximity labeling reveals a new in vivo network of interactors for the histone demethylase KDM5

  2023cites this paper
• KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic.

  2023cites this paper
• Lysine-Specific Demethylase 1 Promises to Be a Novel Target in Cancer Drug Resistance: Therapeutic Implications.

  2023cites this paper
• Correlation of sCCL14 with BCLC stage, lymphocyte profile, and response to transarterial chemoembolization in patients with hepatocellular carcinoma.

  2023cites this paper
• Bioinformatic Analysis of Prognostic Value of SNTG2 with Immune Implications in Lung Adenocarcinoma

  2022cites this paper
• Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis

  2022cites this paper
• Chemokine CCL14 affected the clinical outcome and correlated with immune infiltrates in thyroid carcinoma.

  2022cites this paper
• KDM5A/B promotes HIV-1 latency and KDM5 inhibitors promote HIV-1 lytic reactivation

  2022cites this paper
• Targeting Chromatin-Remodeling Factors in Cancer Cells: Promising Molecules in Cancer Therapy

  2022cites this paper
• Changes in epigenetic information during the occurrence and development of gastric cancer.

  2022cites this paper
• The CC ligand chemokine family members CCL17/CCL22 predict the survival and response to immune checkpoint blockade therapy of patients with head and neck squamous cell carcinoma.

  2022cites this paper
• A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance

  2022influential citation
• JMJD family proteins in cancer and inflammation

  2022cites this paper
• CCL14 exacerbates intraplaque vulnerability by promoting neovascularization in the human carotid plaque.

  2022cites this paper
• Functions and Interactions of Mammalian KDM5 Demethylases

  2022cites this paper
• Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or Activator?

  2022cites this paper
• A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors.

  2022cites this paper
• A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer

  2022cites this paper
• NuRD complex recruitment to Thpok mediates CD4+ T cell lineage differentiation

  2022cites this paper
• Zbtb46 Controls Dendritic Cell Activation by Reprogramming Epigenetic Regulation of cd80/86 and cd40 Costimulatory Signals in a Zebrafish Model

  2022cites this paper
• Targeting the LSD1-G9a-ER Stress Pathway as a Novel Therapeutic Strategy for Esophageal Squamous Cell Carcinoma

  2022cites this paper
• Histone Methylases and Demethylases Regulating Antagonistic Methyl Marks: Changes Occurring in Cancer

  2022cites this paper
• Awakening KDM5B to defeat leukemia

  2022cites this paper
• A PRC2-Kdm5b axis sustains tumorigenicity of acute myeloid leukemia

  2022cites this paper
• BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer

  2022cites this paper
• Expression and prognostic values of ARID family members in breast cancer

  2021cites this paper
• The roles of epigenetics in cancer progression and metastasis.

  2021cites this paper
• Microglia-derived interleukin-10 accelerates post-intracerebral hemorrhage hematoma clearance by regulating CD36.

  2021cites this paper
• KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance

  2021cites this paper
• Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy.

  2021cites this paper
• Identi cation of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune in ltration in bladder cancer

  2021cites this paper
• The Role of H3K4 Trimethylation in CpG Islands Hypermethylation in Cancer

  2021influential citation
• The epigenetic and morphogenetic effects of molecular oxygen and its derived reactive species in development.

  2021cites this paper
• CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology

  2021cites this paper
• Identification of early diagnostic biomarkers via WGCNA in gastric cancer.

  2021cites this paper
• Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer

  2021cites this paper
• Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1–CoREST interactome during embryonic stem cell differentiation

  2021cites this paper
• Mining the plasma-proteome associated genes in patients with gastro-esophageal cancers for biomarker discovery

  2021cites this paper
• A functional LSD1 coregulator screen reveals a novel transcriptional regulatory cascade connecting R-loop homeostasis with epigenetic regulation

  2021cites this paper
• The Role of Histone Lysine Methylation in the Response of Mammalian Cells to Ionizing Radiation

  2021cites this paper
• Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

  2021cites this paper
• Prominent Role of Histone Modifications in the Regulation of Tumor Metastasis

  2021cites this paper
• CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4

  2020cites this paper
• Hypoxia-Mediated Regulation of Histone Demethylases Affects Angiogenesis-Associated Functions in Endothelial Cells

  2020cites this paper
• Targeting histone demethylase KDM5B for cancer treatment.

  2020cites this paper
• Geometric regulation of histone state directs melanoma reprogramming

  2020cites this paper
• Identi cation of molecular markers associated with the progression and prognosis of lung adenocarcinoma:a bioinformatic study

  2020cites this paper
• CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma

  2020cites this paper
• Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions.

  2020cites this paper
• C-C motif chemokine 14 as a novel potential biomarker for predicting the prognosis of epithelial ovarian cancer

  2020cites this paper
• Characterization of Leading Dysregulated Plasma-Proteome Associated Genes in Patients with Gastro-Esophageal Cancers.

  2020cites this paper
• Epigenetic Regulator Enzymes and Their Implications in Distinct Malignancies

  2020cites this paper
• Emerging of lysine demethylases (KDMs): From pathophysiological insights to novel therapeutic opportunities.

  2020cites this paper
• Lysine demethylase 5B suppresses CC chemokine ligand 14 to promote progression of colorectal cancer through the Wnt/β-catenin pathway.

  2020cites this paper
• Epigenetics: The master control of endothelial cell fate in cancer.

  2019cites this paper
• Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target.

  2019cites this paper
• MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia

  2019cites this paper
• Molecular architecture of the Jumonji C family histone demethylase KDM5B

  2019cites this paper
• Contribution of H3K4 demethylase KDM5B to nucleosome organization in embryonic stem cells revealed by micrococcal nuclease sequencing

  2019cites this paper
• Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier

  2019cites this paper
• The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism

  2019cites this paper
• Oct4-mediated inhibition of Lsd1 activity promotes the active and primed state of pluripotency enhancers

  2019cites this paper
• LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression

  2019cites this paper
• CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis

  2019cites this paper
• Geometric regulation of histone state directs melanoma reprogramming

  2019cites this paper
• The histone demethylase LSD1 regulates inner ear progenitor differentiation through interactions with Pax2 and the NuRD repressor complex

  2018cites this paper
• Inhibition of Histone Lysine-specific Demethylase 1 Elicits Breast Tumor Immunity and Enhances Antitumor Efficacy of Immune Checkpoint Blockade

  2018cites this paper
• KDM5B overexpression predicts a poor prognosis in patients with squamous cell carcinoma of the head and neck

  2018cites this paper
• Relationship between PIWIL4-Mediated H3K4me2 Demethylation and piRNA-Dependent DNA Methylation.

  2018cites this paper
• Metabolic Induction of Trained Immunity through the Mevalonate Pathway.

  2018cites this paper
• Imbalance of the reciprocally inhibitory loop between the ubiquitin-specific protease USP43 and EGFR/PI3K/AKT drives breast carcinogenesis

  2018cites this paper
• KDM1A microenvironment, its oncogenic potential, and therapeutic significance

  2018cites this paper